Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06786650
PHASE4

Comparision of the Analgesic Effects of Intravenous Ibuprofen and Tenoxicam in Acute Migraine Attack

Sponsor: Haydarpasa Numune Training and Research Hospital

View on ClinicalTrials.gov

Summary

The aim of this clinical trial is to compare the efficacy of two different non-steroidal anti-inflammatory analgesic drugs in the palliation of headache in acute migraine attack. The main questions it aims to answer are: 1. Is there a difference between the efficacy of two different nonsteroidal anti-inflammatory analgesics? 2. Is there a significant difference between the side effects of two different nonsteroidal anti-inflammatory drugs? Researchers will compare intravenous tenoxicam to intravenous ibuprofen to see if tenoxicam works to treat migraine attack. Treatments will; 1. be administered in 100 cc saline to ensure blinding in the group. 2. Randomisation will be done by closed envelope method. 3. Numerical Pain Scale (NRS) will be used to evaluate the analgesic efficacy of the drugs. NRS scores will be recorded in both groups before starting treatment (baseline) and at 30, 60 and 120 minutes after treatment. 4. Any side effects due to medication will be recorded.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2024-05-15

Completion Date

2025-06-30

Last Updated

2025-06-26

Healthy Volunteers

No

Interventions

DRUG

Tenoxicam Injectable Product

Analgesic efficacy of the two active agents analysed in our study in acute migraine attack has not been compared before.

DRUG

ibuprofen

Analgesic efficacy of the two active agents analysed in our study in acute migraine attack has not been compared before.

Locations (1)

Haydarpasa Numune Training and Research Hospital

Istanbul, Uskudar, Turkey (Türkiye)